Medicamen Organics Limited Announces Availability of Valuation Report for EGM
Medicamen Organics Limited issued an update confirming the availability of a key valuation report related to its upcoming Extraordinary General Meeting (EGM). The company noted that the valuation report, issued by M/s Jhamb & Associates, Company Secretaries and Registered Valuer, was dated March 12, 2026.The valuation report was conducted in accordance with the SEBI (ICDR) Regulations, 2018, and relates to matters seeking shareholder approval for the EGM.
Medicamen Organics Limited referred to previous communications regarding the meeting, specifically citing previous submissions made on March 17, 2026, and March 27, 2026, concerning the Notice of the Extraordinary General Meeting.
The company informed stakeholders that the valuation report dated March 12, 2026, can be accessed from the company’s official website.
MEDIORG Stock Price Movement
Shares of Medicamen Organics Limited slipped by 10.00% on Friday, settling at ₹24.45. The stock saw significant activity, trading a total volume of 86,000 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.